Is 530825 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 530825 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 530825's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 530825's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 530825?
Key metric: As 530825 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for 530825. This is calculated by dividing 530825's market cap by their current
book value.
What is 530825's PB Ratio?
PB Ratio
12.8x
Book
₹96.54m
Market Cap
₹1.31b
530825 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: 530825 is expensive based on its Price-To-Book Ratio (12.8x) compared to the Indian Chemicals industry average (2.7x).
Price to Book Ratio vs Fair Ratio
What is 530825's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
530825 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
12.8x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate 530825's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.